Home
BML Investment Partners reported a 9.95% stake in enGene Therapeutics ENGN · 6,669,908 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 9.95%
- Last report
- 7.8% · filed 26/05/13
- Shares held
- 6,669,908 sh
- Class
- Common Shares
- Holder
- BML Investment Partners
- Event date
- 26/05/12
- Filed
- 26/05/14
9.95% stake · +2.1pp from the last report
- Stake
- 9.95%
- Last report
- 7.8%
- Since last report
- +2.1pp
enGene Therapeutics trades, last 26 weeks
What else happened in enGene Therapeutics around then
Filed or reported within 30 days of the trade day · 04/12~06/11BML Investment Partners's other 5% stake reports
- BML Investment Partners
5% stakeOramed Pharmaceuticals
5% stakeOramed Pharmaceuticals
ORMP
2.5% stake
1,026,269 sh
2.5% stake
Filed 06/29
- BML Investment Partners
5% stakeOutset Medical
5% stakeOutset Medical
OM
13.6% stake
2,519,701 sh
13.6% stake
Filed 05/18
- BML Investment Partners
5% stakeenGene Therapeutics
5% stakeenGene Therapeutics
ENGN
7.8% stake
5,225,000 sh
7.8% stake
Filed 05/13
- BML Investment Partners
5% stakeOutset Medical
5% stakeOutset Medical
OM
11.8% stake
2,196,701 sh
11.8% stake
Filed 05/12
- BML Investment Partners
5% stakeAclaris Therapeutics
5% stakeAclaris Therapeutics
ACRS
9.9% stake
13,950,000 sh
9.9% stake
Filed 04/27
